Anti-p53 antibody [E26] (Ab32389)
P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53
详细信息
特异性
The antibody should recognize human wild-type and mutant p53.
背景信息
What is this antibody validated in? Anti-p53 antibody [E26] (ab32389) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of p53? Anti-p53 [E26] (ab32389) specifically detects a band for p53 (UniProt: P04637) at a molecular weight of 44kDa. Trusted by the scientific community Anti-p53 [E26] (ab32389) was first used in a scientific publication in 2006 and has been cited over 110 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-p53 antibody [E26] (ab32389) has been confirmed by Western blot testing in TP53 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [E26] also available for your convenience: ab32389, Alexa Fluor ® 647 - ab224942, Alexa Fluor ® 488 - ab224943, Carrier free - ab225531, APC - ab310855, PE - ab310924, Alexa Fluor ® 594 - ab311727, Alexa Fluor ® 568 - ab313004, Alexa Fluor ® 555 - ab313208, Alexa Fluor ® 750 - ab321599 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (135)
Diagnostic and prognostic signatures of glomerular membrane dysregulation in immune nephropathies.
免疫性肾病中肾小球膜功能紊乱的诊断和预后特征。
Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents.
苯乙烯基修饰的3,4-二氢嘧啶-2(1H)-酮作为潜在抗肿瘤药物的开发。
STOML2 Alleviates Osteoarthritis by Regulating Mitochondrial Energy Metabolism and Oxidative Stress.
STOML2 通过调节线粒体能量代谢和氧化应激来缓解骨关节炎。
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.
持续的基因组倍增塑造了卵巢癌的进化能力和免疫力
HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency
HIV感染会将CD4+ T细胞重编程,使其进入静止状态并进入前病毒潜伏期。
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma
整合单细胞生物物理和转录组特征以解析套细胞淋巴瘤的功能异质性
Glutathione reductase underlies the stability of mutant p53 by antagonizing protein glutathionylation
谷胱甘肽还原酶通过拮抗蛋白质谷胱甘肽化来维持突变 p53 的稳定性
LINE1 insertion into the NACC2 locus disrupts the HDM2 axis and activates lung oncogenic signaling.
LINE1 插入 NACC2 位点会破坏 HDM2 轴并激活肺致癌信号
Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress.
靶向 ESR1 可恢复 SQSTM1 依赖性自噬,并使 ER 阳性乳腺癌对氧化应激和辐射应激更加敏感。
Premature renal epithelial cell senescence promoted by LXN/Rps3/p53 signaling pathway activation increases calcium oxalate crystal deposition by altering macrophage polarization.
LXN/Rps3/p53 信号通路激活促进的肾上皮细胞过早衰老通过改变巨噬细胞极化增加草酸钙晶体沉积。
- 1
- 2
- 3
- 4
- 5
- 6
- 14